6.3184

0.13% +0.0084

Trxade Health Inc (MEDS)

Overview News Price History Discussions Forecast Stock Split

Trxade Health Inc stock is currently priced at $6.3184, with a 24-hour trading volume of 9,649. It has seen a +0.13% increased in the last 24 hours and a -38.30% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $6.18 pivot point. If it approaches the $6.55 resistance level, significant changes may occur.

Previous Close:

$6.31

Open:

$6.28

24h Volume:

9,649

Market Cap:

$8.83M

Revenue:

$10.01M

Net Income/Loss:

$-7.10M

P/E Ratio:

-17.55

EPS:

-0.36

Net Cash Flow:

$-91,000

1W Performance:

-5.13%

1M Performance:

-38.30%

6M Performance:

+2.57%

1Y Performance:

+1,791%

1D Range:

$5.9201

$6.88

52W Range:

$0.265

$44.56

Trxade Health Inc Stock (MEDS) Company Profile

Name

Trxade Health Inc

Sector

Healthcare (1203)

Industry

Pharmaceutical Retailers (10)

Phone

800-261-0281

Address

3840 Land O' Lakes Boulevard, Land O'Lakes, FL

Employee

Twitter

@Trxade

Next Earnings Date

2024-05-13

Latest SEC Filings

MEDS's Discussions on Twitter

Trxade Health Inc Stock (MEDS) Latest News

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views

Benzinga

Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Crude Oil Rises Sharply; Foot Locker Shares Plunge

Benzinga

Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday

Benzinga

TRxADE Health, Inc. Announces Special Cash Dividend

GlobeNewswire Inc.

Trxade Health Inc Stock (MEDS) Financials Data

Trxade Health Inc (MEDS) Revenue 2024

MEDS reported a revenue (TTM) of $10.01 million for the quarter ending September 30, 2023, a -8.68% decline year-over-year.

Trxade Health Inc (MEDS) Net Income 2024

MEDS net income (TTM) was -$7.10 million for the quarter ending September 30, 2023, a -113.22% decrease year-over-year.

Trxade Health Inc (MEDS) Cash Flow 2024

MEDS recorded a free cash flow (TTM) of -$91.00 thousand for the quarter ending September 30, 2023, a +97.41% increase year-over-year.

Trxade Health Inc (MEDS) Earnings per Share 2024

MEDS earnings per share (TTM) was -$10.01 for the quarter ending September 30, 2023, a -65.45% decline year-over-year.

Trxade Group, Inc. owns and operates a business-to-business Web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade, Inc.; Community Specialty Pharmacy, LLC; and Other segments. The company operates a Web based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com, a Web-based pharmaceutical marketplace; InventoryRx.com, a Web-based pharmaceutical exchange platform; Pharmabayonline that provides proprietary pharmaceutical data analytics and governmental reimbursement benchmarks analysis to the United States-based independent pharmacies and pharmaceutical databases; and RxGuru, a desktop application, which provides product information. The company also operates a retail specialty pharmacy. In addition, it operates Delivmeds.com, a consumer-based app to provide delivery of pharmaceutical products; and Trxademso.com to assist independent retail pharmacies on pricing, distribution, and logistics. Trxade Group, Inc. is based in Land O'Lakes, Florida.